Skip to content

Impact of Intratechal Clonidine in analgesia in elective cesarean

Impact of Intratechal Clonidine in analgesia in elective cesarean

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT138901212080N3
Enrollment
166
Registered
2010-05-17
Start date
2010-04-10
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

elective cesarean. Delivery by elective caesarean section

Interventions

Intervention 1: 75-100 mg Intratechal Lidocaine 5%. Intervention 2: 75-100 mg Intratechal Lidocaine 5%+75 mcg Intratechal Clonidine.
Treatment - Drugs
75-100 mg Intratechal Lidocaine 5%
75-100 mg Intratechal Lidocaine 5%+75 mcg Intratechal Clonidine

Sponsors

Arak university of medical sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1. age: 15-40 2. ASA score I, II 3. Elective and term cesarean; Exclusion criteria: 1. Emergent cesarean 2. Fetal perinatal distress due to thick meconium, deculment or low APGAR score 3. Patient`s low compliance for entering the study and spinal analgesia 4. positive history of preeclampsia, chronic hypertension, consumption of B-blockers, Antipsychotics or Anti depressants 5. Perioperative Anti emetics use

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Analgesia. Timepoint: Immediately after recovery admission then each 4 hours for 12 hours. Method of measurement: VAS(Visual Analage Scale).

Secondary

MeasureTime frame
Mother`s pulse rate & blood pressure. Timepoint: each 5 minutes for the first 20 minutes,each 10 minutes till recovery discharge,each 4 hours for 12 hours. Method of measurement: physical exam & check list.;Neonate`s APGAR score. Timepoint: first,fifth and tenth minutes. Method of measurement: check list.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAfsaneh Norouzi

Arak University of Medical Sciences

norouzi.a@arakmu.ac.ir+98 86122247900

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026